Lingmed team on behalf of Biotechgate cordially invites all life sciences and non-profit organizations to an online partnering event from Aug 31 - Sep 3, 2020. Meeting requesting system will open soon and we expect to have over 1,500 delegates registered for the event incl. small Biotech and big Pharma companies. Lingmed's Biotechgate clients can participate this online partnering event with VIP complimentary pass. Please reach out to your support team or account managers.
ChinaBio® Partnering Forum has grown to be the premier life science partnering conference in China since 2009. This year is our 12th anniversary, and for the first time will be delivered digitally! The conference will take place on August 25-27, using the powerful online platform provided by EBD Group, the largest provider of life science partnering events globally. Last year, there were over 1400 attendees from 25 countries who had over 3,200 1-1 meetings and saw nearly 80 company presentations during the 2-day conference. This year, going virtual will enable participants to hold meetings 24/7 using EBD Group's partneringONE® system, and to see the company presentations, keynote panels and workshops throughout the event. Join us this year for what will prove to be a dynamic and exciting event that will enable you to meet with colleagues from around the world, and to hear from executives, investors and industry experts from leading Chinese and global companies, as well as innovative startups.
Lingmed subscribers enjoy 20% discount using registration code ‘LM20’
Lingmed subscribers enjoy 20% discount using registration code ‘LM20’
The Largest Biotech Business Event in Asia!
Jointly organized by both the Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan BIO). This year's event will be a unique blend of Online and Live gatherings, held on July 22-26 in Taipei, Taiwan with sessions streaming online. This event brings together biopharma executives and investors from Asia, North America, and Europe to meet and explore business opportunities with Taiwan’s emerging biotech sector in both Online and live settings. The five-day event will feature online company presentations, BIO One-on-One Partnering™, online seminars and workshops, and an online exhibition. It is a rare opportunity to reach out to Asia and Global Partners during the Pandemic! Conference agenda is now available at bioasiataiwan.com
The Asia Pharma Manufacturing Congress 2020 is one of the high-level strategic summits in the pharmaceutical industry in Asia. The top four global pharmaceutical markets are the United States, China, five European countries and Japan. Asia has an important status in the global pharmaceutical market and is growing rapidly. In recent years, the Chinese state has frequently issued policies on the pharmaceutical industry, vigorously reformed and pushed the policies into practice.
Being a pharmaceutical leader was once all about what you could sell. Marshalling your troops like a grand army, ready to fight for your share of voice. Today, we need a new kind of leadership – one that is authentic, all about data-driven decision-making, regulatory-grade real-world evidence, value-based access and empowering medical on the front line. To affect this change, 2000+ pharma-decision makers (from across Commercial, Sales, Marketing/Digital, IT, Medical, Patient Engagement, Market Access, RWE and Clinical) will join healthcare innovators on their yearly journey to the 18th eyeforpharma Barcelona Conference.
BIO-Europe Spring® is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe®, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group’s sophisticated, web-based partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative startups.
World Pharma Pricing Market Access & Evidence Congress 2020
March 18–19, 2020, Amsterdam, Netherlands
The World Pharma Pricing and Market Access Congress is Europe’s largest market access and pricing conference. Bringing together industry leaders from pharma companies, payers and HTAs, PPMA provides excellent opportunities to hear from patient led organisations, healthcare providers and other industry bodies. Join us in Amsterdam to discuss pricing, RWE, patient centricity and global market access all in one place.
BIO Asia International Conference is an exclusive partnering forum that brings together the global biotechnology and pharmaceutical industry with Japanese licensing and business development executives to explore licensing and investment deals.
The 10th Asia Pharma R&D Leaders Summit is one of the high-level strategic summits in the field of pharmaceutical R&D in Asia. This conference will gather together experts and senior executives from Chinese pharma companies, biotechnology companies, multinational pharmaceutical companies, research institutes and other companies, who are persisting in fighting for patients’ health on the front line of new drug R&D, discussing the status and trends of new drug R&D, exploring on strategy innovation and changes of drug development, clinical R&D and decision-making
Based on the transformation &upgrading and policy reform of China’s pharmaceutical industry, and theprevious successful experience of last session, China International Biopharma4.0 Summit(2020) will further deepen topics concerning the implementation of specific policies and regulations on the biological cell culture technology, protein characterization and optimization and ICH-Q series, and discuss more practical topics such as Pharma 4.0, the latest progress in technologies, future trends, digitization and intelligence of biopharma companies, CGMP quality management system from laboratories to plants, regulations on the use of SUS, optimization of cell culture technology, advanced experience of upstream and downstream biopharma technology, and outsourcing technology development IP.
Come and meet us during AgeingFit on January 28th and 29th, 2020 in Nice! AgeingFit is the leading Europen event dedicated to innovation in the Healthy Ageing sector. For its 4th edition, AgeingFit will gather healthy ageing companies, service providers, accommodation and care facilities, private and public research institutes, specialized associations and clusters, investors, health insurance providers, legislators and institutions… Their goal? Fostering business, research and financial partnerships with the objective to launch innovative products and services to the senior market.
Join this one-day program right before Biotech Showcase™. China Showcase provides invaluable opportunities to expand your network with the most influential and experienced leaders in cross-border investment and business development transactions. Don't miss this opportunity to meet with leading industry investors and potential partners from China, US and EU. Through our partnership with EBD Group we are able to offer you this exclusive discount.
Presenting at Biotech Showcase allows companies to build their profile with investors and strategic partners. In addition, presenters can conduct one-to-one meetings and participate in informal networking. Hear the latest industry trends in workshops and panels featuring key biotech leaders, investors, pharma executives, and other industry advisors.
"P4 China 2019 4th International Precision Medicine Convention " will be upgraded on the basis of rich experience successfully held in the past three years. More than 80 leading entrepreneurs, scientists and medical researchers will be invited to share multi-disciplinary research, analysis and mining of big biomedical data and application of artificial intelligence, early screening and early diagnosis of diseases, clinical individualized medication,precise drug development and real world research in five special forums,which will bring about an ideological collision between industry, university and research
TCome and join us at the 8th edition of BioFIT, on the 10th and 11th of December 2019 in Marseille, France! With the highest attending rate of TTOs, research institutes and academia together with big pharma, emerging and small biotech, diagnostics companies, pre-seed / seed / Series A investors, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovation deals in the field of Life Sciences. BioFIT is also the European marketplace for pre-seed, seed and Series A investment in Life Sciences.
How China’s healthcare pathfinders are leveraging the nation’s innovation, policy initiatives and access to capital markets in HK and domestic exchanges to build a globally facing industry. Six years ago, the first China Healthcare Summit asked how the nation would build the “Bridge to Innovation.” In 2019, we examine how China is now actually building the Bridge to Global Healthcare. A full two-day program highlighted by dialog among China-facing biotech innovators and their globally-facing Chinese counterparts.
The World Orphan Drug Congress and Cell & Gene Therapy is the meeting place for the rare disease community. The agenda covers the strategic and commercial aspects of bringing new treatments to patients who suffer from rare diseases. Government authorities, payers, industry and patient advocacy groups are all joining us. You can also meet biotech start-ups and investors who are showcasing their orphan drug technology and pipeline.
After a few years of tremendous growth and the creation of many new Chinese biotechs, 2019 is proving to be the year where they hone their strategies that will enable success for the long term. Industry dynamics have shifted: VC funding is much harder to come by, competition for development talent is fierce, and the field of companies vying for a share in hot new areas such as immuno-oncology/CAR-T is getting over-crowded. Where is the industry headed next and what are the implications for drug developers in China? Join 350+ senior-level clinical development executives from MNC and domestic biopharmas as they gather to discuss the next steps for the industry.
BIO-Europe® 2019 - 25th Annual International Partnering Conference
November 11–13, 2019, Hamburg, Germany
The 25th annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 4,350 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.
Come and join us and the other 600 international participants at the 6th edition of NutrEvent, on October 22nd & 23rd, 2019 in Rennes, France! NutrEvent is the leading European partnering event dedicated to innovation in Food, Feed, Nutrition and Health. It aims at identifying industrial, scientific, commercial and financial partners for your innovation projects. NutrEvent gathers 600+ international actors: ingredient suppliers and distributors, finished food product and food supplement industries, academic institutions, technology transfer organisations, research institutes, R&D services and consulting firms and investors.
Bio Partnering APAC 2019 is the most powerful way to make big deals in bio pharma industry in Asia Pacific Region. Against the background of increasing government policy support, exciting biotechnology breakthroughs and growing venture capital investment, themed on “R&D Strategy Innovation under New Regulatory Policy, Collaboration Opportunity under New Global Situation”.
To promote the capitalization and industrialization of pharmaceutical innovative achievements, encourage more investment to Chinese pharmaceutical innovation industry, facilitate the timely transformation of unmet clinical needs, China Pharmaceutical Innovation and Research Development Association (PhIRDA) will host the 2019 China BioMed Innovation and Investment Conference (2018 CBIIC) in Suzhou Industrial Park on September 21-23, 2019. The theme of 2019 CBIIC is "Promote the linkage between social capital and pharmaceutical innovation, improve innovation capability of pharmaceutical industry".
BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Life science executives from around the world gather to identify, meet and to enter into strategic relationships facilitated by partneringONE®.
With a record 1000+ participants, the ISPE Singapore Conference and Exhibition broke new ground in 2018. We saw a strong presence of Pharma and Manufacturers, supported in equal measure my Regulators, EPCM, and various other stakeholders and service providers. Focused and insightful learning outcomes alongside the many networking opportunities created an undeniable buzz amongst all participants, and PharmaNite in particular was a roaring success. The ISPE Singapore affiliate would like to thank industry for its support, and endorsement of the fact that this high quality conference and exhibition is now the preeminent gathering for industry in ASEAN
Co-organized by the global Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan BIO), the inaugural BIO Asia-Taiwan 2019 Conference and Exhibition will be held in Taipei, Taiwan 24-28 July, 2019. A week-long festival of biotech-themed conferences, meetings, and presentations, BIO Asia-Taiwan is poised to become Asia’s most important gathering of the biotechnology community. Join 1,500 participants from 25 countries at the three-day conference for sessions on AI for healthcare, advances in precision medicine, cell and gene therapies, M&A in the healthcare sector, and more.
Held on the 25th and 26th of June 2019 in Lille – France, and gathering 700 international participants from over 25 countries, MedFIT is the leading European business convention dedicated to innovation partnerships in the fields of medical technology, diagnostics and digital health sector. MedFIT is the place-to-be to identify innovative products and technologies, to build R&D, find licensing opportunities and financial partnerships. MedFIT brings together industry leaders, innovative MedTechs, diagnostics start-ups, TTOs, academic institutions, R&D services as well as companies and investors to help facilitate market access for innovations.
The 7th Vaccine China Leaders Annual Meeting 2019 is one of the most top Strategic Vaccine Summits in China and even Asian region, which annually focuses on the Innovative Development and Strategic Partnership of the Whole Vaccine Industry Chain. Themed on “Innovation, Cooperation, Efficiency, Safety”, by two separate Human /Animal Vaccine Forums, the VacChina 2019 will invite the Leading Executives and Decision Makers from the global Vaccine R&D and Manufacturers, Biotech Companies, Academic Institutes, Governmental and Public Health
With demonstrated success year on year, IBC’s BioPharma Development and Production Week in China enjoys unparalleled industry support. Known for generating knowledge, creating business opportunities, and bringing innovative ideas to the table, the BDP Week is now more impactful than ever with 5 high level conferences, learning seminars, focused trade show and business matching to boot. 400+ participants will get to hear from over 100 local and global experts, and reap the benefit of a unique business matching opportunity. Regulation, growth trends, digitalisation, technology innovation and partnering will form the bedrock of the 5 co located conferences.
The future of biomanufacturing is set for a revolution. New outsourcing trends, mass customisaton and precision medicine, intensification versus continuous models, and the rise of intelligent facilities, are but some of the issues driving the change. Smart biomanufacturing is increasingly playing a crucial role in fulfilling the needs of the market
China steadfastly continues to work regulations on biosimilars to help make the market easier to breakthrough, and the recent Priority Review legislation is a case in point. As the industry continues to evaluate cost, risk and incentives for Biosimilar development, new developments to promote R&D and adjustments to approval pathways are designed to help manufacturing and commercialization of biosimilars
The cell therapy market is exploding with opportunities, and the total market volume for CAR-T therapy alone is expected to reach USD 1 trillion by 2030. China boasts more cell therapy trials than the US, and it is increasingly leveraging its strategic advantage in context to labour costs, precision manufacturing, and now also a more accommodating regulatory regime for this sector
Recent regulatory developments have invigorated China’s clinical trials industry. Greater flexibility to encourage innovation, the 60 day CDE timeline for Phase 3 trials, site accreditation process revamp, acceptance of foreign data towards new drug applications, are just some of the measures expected to generate renewed enthusiasm amongst foreign and local sponsors
The global market size for cell line development is expected to exceed USD 7.5 billion by 2024. Some key market drivers include the demand for cell therapies, growing oncology market, increasing demand for vaccines and monoclonal antibodies, and continued growth in the vaccine market
ChinaBio® Partnering Forum is the premier life science partnering event in China since 2009. Our 11th annual conference will be held on May 8–9, 2019 in Shanghai, China. The event will attract over 1,400 biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for two days of productive partnering. ChinaBio® Partnering Forum 2018 had more than 1,200 delegates from over 500 companies and 25 countries, over 2,500 one to one meetings, 80 company presentations, 900+ licensing opportunities , and 70% of the attendees from China, making it the largest international partnering conference in China
The 11th Annual China Healthcare Investment Conference (CHIC) will highlight the latest healthcare investment opportunities in light of China's recent major policy reforms aimed to bring domestic innovation to the global stage. As always, CHIC features perspectives from leading venture capital, private equity, and public equity investors as well as prominent Chinese and international healthcare companies
BIO-Europe Spring® is the springtime counterpart to EBD Group's flagship conference, BIO-Europe®, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group's sophisticated, web-based partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative startups
Deep integration of next-generation ICT technologies and manufacturing industry is driving a round of industrial transformation, creating new manufacturing methodologies, industrial forms, business modes and economic growth. All countries are encouraging innovation in science and technology. Following Germany's Industry 4.0 announcement, China released Made in China 2025, a national strategy to accelerate the transformation and upgrading of manufacturing industry which is led by smart equipment, smart factory and smart manufacturing based on cyber-physical System (CPS)
The 16th annual BIO Asia International Conference is an exclusive partnering forum that brings together the global biotechnology and pharmaceutical industry to explore licensing collaborations and investor engagement in the current Asia-Pacific business and policy environments. Gain insights into the changes, challenges, and opportunities key opinion and policy leaders foresee for the Japanese biotech market
Asia Pharma R&D Leaders 2019 is designed to be a premium strategic platform for big pharmas, biotechs, academia and other stake holders in pharma industry to meet, communicate and establish partnership on pharma R&D. Leading executives will discuss key topics of global R&D trends, development strategies, innovation capability building and collaboration opportunities
Biotech Showcase™ is an investor and networking conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world
Join this one-day program right before Biotech Showcase™. China Showcase provides invaluable opportunities to expand your network with the most influential and experienced leaders in cross-border investment and business development transactions. Don't miss this opportunity to meet with leading industry investors and potential partners from China, US and EU. Through our partnership with EBD Group we are able to offer you this exclusive discount. Save USD 200 when you register with Lingmed discount code LM200CS19
PHARMCHINA is a long-established trade fair for pharmaceutical preparations, health products and related technologies and services in China. As a platform for domestic pharmaceutical preparations, health products and related technologies, such as service trade, information exchange platform and cooperation docking and learning, the PHARMCHINA advocates the concept of “medical science and technology to create a healthy future” and promotes the Chinese pharmaceutical industry together with the whole industry to an innovation-driven, endogenous growth, and expansion of the overall sustainable development path
2018 International Life Health Industry (Shanghai) Exhibition & Summit Forum
November 23-25, 2018, Shanghai, China
2018 International Life Health Industry (Shanghai) Exhibition & Summit Forum ( “Life Health EXPO” in short) kept its subject of “ Life enlivens today, health serves tomorrow” in Shanghai Private Health Management EXPO. By sectors, it displays the platform for the entire industrial chain of Life Science, Biotechnology, Research & Development, Manufacturing and Applications, with exhibition areas of Life & Big Health, Life Science Simulation, Innovative Biotechnology, Life Industrial Park and other exhibition areas
Five years ago, the first China Healthcare Summit asked how the nation would build the “Bridge to Innovation.” In 2018, we examine how China is now actually building the Bridge to Global Healthcare. A full two-day program highlighted by dialog among China-facing biotech innovators and their globally-facing Chinese counterparts. The China Summit is a VIP-only event for busy biopharma and life sciences executives and investors to get a first-hand look at the innovation, business and policy transformations taking place in China. The conference is THE place to meet the right Chinese investors and partners in an intimate setting
The 24th annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 4,000 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners
Biopharma Development & Production Asia-Pacific
November 1-2, 2018, Singapore, One Farrer Hotel & Spa
The annual Biopharma Development & Production (BDP) Asia Pacific returns with a refreshed agenda across 3 co-located conferences, spanning Bioprocess and Technology, Biotech Investment, as well as Biopharma Supply Chain Management.
With the increased adoption of innovative technology and investments in advanced R&D, coupled with higher manufacturing output, these are shaping to be the key drivers of the industry in the next few years. Hear from 40+ global and regional experts as they share exclusive insights at market-facing sessions and panel discussions
With the increased adoption of innovative technology and investments in advanced R&D, coupled with higher manufacturing output, these are shaping to be the key drivers of the industry in the next few years. Hear from 40+ global and regional experts as they share exclusive insights at market-facing sessions and panel discussions
Phamacon organizing committee will provide the most top-level conference platform for Chinese chemical enterprises, and promote the exchange and progress of the whole industry. The summit will gather more than 500 domestic and foreign leading chemical companies and leaders of drug regulatory agencies to explore common difficulties and challenges faced by domestic and foreign pharmaceutical enterprises, such as policies and regulations, R & D technology and development trends. Looking forward to welcoming you in Pharmacon 2018!
Best Media is pleased to announce the launch of the 8th Annual Drug Delivery and Formulation Asia Summit at Wyndham Bund East Shanghai Hotel in China on Oct.25 & 26, 2018. This summit provides drug delivery and specialty pharmas with a platform to present their technologies and get the latest insights on what the delivery and formulation needs are. And presents a strategic level program for pharma and business development professionals with a thorough overview of the latest drug delivery technologies available along with an update on deals and opportunities to improve therapies and extend the life cycle of a drug
The 13rd BD Forum will be held in Ningbo on October 24-26. The forum aims to explore how pharmaceutical and medical companies can expand their business and investment opportunities in the face of global changes, promote rapid growth in integration, and achieve “embrace globally and achieve value”
A multi-professional platform for oncology education and exchange, and for immense international visibility for scientific research, this year the Congress also features a dedicated nursing track through a collaboration with the European Oncology Nursing Society (EONS)
Lingmed sincerely invite you to this insights sharing and strategic discussions on what has happened and is happening to the China life sciences market. Please join us on 19 September at Webex to exchange your views and make yourself ready for the rapidly changing market
BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Life science executives from around the world gather to identify, meet and to enter into strategic relationships facilitated by partneringONE®, the world's leading web-based partnering system. BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®
BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Life science executives from around the world gather to identify, meet and to enter into strategic relationships facilitated by partneringONE®, the world’s leading web-based partnering system. BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®.
The Antibody and Antibody-based Therapeutics have entered the center stage of drug discovery. Roughly, as of end of 2017, over 70 antibody therapeutics have been approved. Not only in Western Countries, there have been also considerable Biologics R&D, manufacturing and commercial activities in China/Asia. In 2015, the China FDA also received the country's first biosimilar guidelines to establish the basic principles for development and technical evaluation of biosimilars towards the adoption of a more concrete and well-defined regulatory pathway. In return, the 2018 Antibody-based Therapeutics and BioProduction Forum is to build up and facilitate the communication and partnerships to accelerate Biologics R&D, Characterization and Production
Organised by the Singapore affiliate of the International Society for Pharmaceutical Engineering (ISPE), this annual meeting is open to all pharma and bio manufacturing Professionals. Building on the theme “Innovating for Next Generation Pharma Manufacturing”, it is the must-attend industry event which highlights best practices, technology and services from manufacturing facility design to finished product. In 2017, the event attracted 800+ participants and visitors from 26 countries and has established itself as a pre-eminent platform for Pharma, CMOs, Vaccine companies, Medical Device manufacturers, Researchers, Engineering and EPCM, Academia and wider service providers
BioTaiwan, one of the largest biotech gatherings in Asia features 3-day BioBusiness Asia Conference (BBA) focusing on precision medicine, innovative investment, advanced technologies, Greater China and ASEAN Opportunities with Company Presentation, One-on-one Partnering, and 4-day Exhibition. In 2017, 1,000+ delegates from 20+ countries attended BBA with 1300 booths from 600+ exhibitors. Join us at BioTaiwan 2018 to network with top executives, catch up with the latest technologies, and find business opportunities abundant in Taiwan, one of the most under-explored biotech locations
The research and development of new drugs ensure that we can obtain the leading strategic position in technological and economic competition throughout the world. The innovation strategy and R&D model are the cores of the development of pharmaceutical companies. China's entry into ICH marks the beginning of new drug development into the New Era of globalization. In the past three years, government departments have established a sustainable environment for innovation in the pharmaceutical industry from the dimensions of policy orientation, technical support, human resources, and capital input.
Facing the needs of project progress management, risk response, supplier selection, and innovation and feedback from clinical trial centers in the process of clinical projects, the BCD2018 (2nd) Biopharmaceutics Clinical Development Summit to be held in CBI will focus on clinical Operational drills, case sharing and other fields in operation. The conference will focus on the exchange of training for the implementation of specific clinical programs after the drug approval IND. It will also provide in-depth exploration of the progress control, risk control, quality control, and other aspects of the clinical program. I hope this meeting will provide a platform for more exchanges, learning and progress for more clinical practitioners
Since our founding in 1964, DIA has provided a global stage for collaboration to address healthcare challenges. As a memberdriven volunteer organization, professionals from 80 countries have engaged with DIA through our unparalleled membership network, educational offerings, and professional development opportunities. Everyone passionate about working at the global intersection of science, healthcare, and regulation come together at DIA. In a uniquely neutra
Shanghai International Forum on Biotechnology & Pharmaceutical Industry (Bio-Forum) has evolved into an influential international conference in the area of biotechnology and pharmaceutical industry. This year, Bio-Forum will be held at Shanghai International Convention Center on May 23-25, 2018. Nearly 100 well-known experts, scholars, entrepreneurs and government officials from home and abroad will be invited to give excellent speech and about 600 delegates will attend the forum. The forum consists of the following parts: Keynote Speech, Parallel Sessions, Partnering, and Exhibition. We are looking forward to meeting you in Shanghai
2018 Shandong Pharmaceutical Industry Development Summit Forum, Sponsored by Shandong Pharmaceutical Industry Association, in order to boost scientific and technological progress in Shandong pharmaceutical industry and improve the independent innovation capability of pharmaceutical companies. Today, it has become an indispensable and important partner for the development of the pharmaceutical industry. Provide assistance and enlightenment on important aspects such as development ideas and solutions to industrial development problems. To bring more practical promotion and opportunities for the development of more industry enterprises. The conference will be held in Jinan, Shandong Province from May 17th to 18th. Welcome your active participation
With 350+ participants representing the core of China’s market, the Biopharma Development & Production Week is back to spur industry learning, showcase innovation and enable business contacts. With 3 co located conferences, 70+ speakers and over 60 technical and commercial sessions, this is without doubt the only forum with demonstrated value add for participants. Against the bedrock of emerging and disruptive technologies, new generation facilities and continuous process improvement, participants will get quality practical information that enables them to develop advance capabilities in developing and manufacturing cell lines, biosimilars, biobetters, antibodies, vaccines and novel biologics
ChinaBio® Partnering Forum has grown to be the premier life science partnering conference in China since 2007. This year, it is our 10th anniversary! The conference will take place on April 24-26 in Suzhou, an emerging hub of life science in Eastern China. Suzhou is committing significant funding and resources to the life science industry, including building the Bio industry, with 204,000 ㎡ of incubator, and manufacturing facilities. ChinaBio® Partnering Forum features EBD Group's partneringONE® system, enabling delegates to efficiently arrange 1-1 meetings with companies from across the life science value chain. Join us at ChinaBio® Partnering Forum 2018, to meet over 1,000 of biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for two days of productive partnering in Suzhou
LINGMED LIMITED SHANGHAI together with Venture Valuation is pleased to invite you to a full-day workshop on pharma – biotech Product and Company Valuation
• Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world
• Know how to assess and calculate the value of a biotech company
• Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal
• Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world
• Know how to assess and calculate the value of a biotech company
• Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal
Taihu (Mashan) Life science and Healthcare Forum - 2018 Biopharmaceutical and Financial Innovation
April 20-22, 2018, Wuxi, China
In order to further promote the reform and development of biopharmaceutical in China and encourage international exchanges and cooperation to discuss Chinese biopharmaceutical industry development plan, the "Taihu (Mashan) Life science and Healthcare Forum - 2018 Biopharmaceutical and Financial Innovation" will be held in Wuxi in April 20-22, 2018. The theme of the conference is "Biopharmaceutical Innovation and Capital Financing". We will invite top experts, scholars, and industry professionals from global biopharmaceutical research and development innovation and financial fields to discuss clinical oncology, protein antibody research, capital financing for biopharmaceutical innovation, new drug delivery systems, research and evaluation of new vaccines topics, etc
To speed up Asian Bioinnovatives and Biosimilars development and to promote industry exchange and cooperation, BioCon China 2018, as the largest and the most professional annual meeting, has 2 streams of forum: 5th World-China Biosimilars Forum and 4th International Symposium on Biopharmaceutical Innovation and Development.
BioCon China 2018 (April 20-21, Shanghai) will assemble 40+ global and China's regulators, tech executives and expert scientists from leading biopharmas, and 500+ professional elites, to deliver and discuss efficient and differentiated R&D strategy for biopharmaceuticals
BioCon China 2018 (April 20-21, Shanghai) will assemble 40+ global and China's regulators, tech executives and expert scientists from leading biopharmas, and 500+ professional elites, to deliver and discuss efficient and differentiated R&D strategy for biopharmaceuticals
The Best Media is pleased to announce the launch of the Generic International Summit Asia 2018 in in Shanghai, China.taking place between the 19th & 20th April 2018. Best Media will gather all the essence and global resources into this conference to bring further information and experience sharing. Speakers at this summit are from the two aspects of the pharmaceutical industry: Regulatory Updates and Technology & Market. Meanwhile, the committee will provide four panel discussion on the specific practice of generics consistency evaluation and Case study and experience sharing for generic submission in overseas market
The 9th Annual China Healthcare Investment Conference (CHIC) theme for 2018 is “Healthcare Innovation: China’s Emergence on the Global Stage” . The 9th Annual China Healthcare Investment Conference (CHIC) will highlight the latest healthcare investment opportunities in light of China’s recent major policy reforms aimed to bring domestic innovation to the global stage. As always, CHIC features perspectives from leading venture capital, private equity, and public equity investors as well as prominent Chinese and international healthcare companies
The 15th Annual BIO Asia International Conference is an exclusive, customized partnering forum that brings together U.S. and European drug development companies with Asian biotech and pharmaceutical companies interested in research and licensing collaborations. BIOASIA17 hosted over 1,200 BIO One-on-One™ Partnering meeting in 2017! Don't miss out on your opportunity to accelerate your pathway to partnership in Asia at #BIOASIA18. Registration is now open! Use code M115642595 for $200 off the Biotech/Pharma company registration rate
eyeforpharma Barcelona is a completely unique experience, bringing together 1300+ influential pharma leaders, who share the same passion for innovation, healthcare and patients. The detailed agenda has just been released, see what J&J, Lily, Sanofi, Takeda, Shire and many more will be sharing during their key note presentations – view here and start scheduling!
BIO-Europe Spring® is the springtime counterpart to EBD Group's flagship conference, BIO-Europe®, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group's sophisticated, web-based partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative startups
Asia Pharma R&D Leaders 2018 is going to be held in Beijing on Jan.24th -25th.This event is designed to be a premium strategic platform for big pharmas, biotechs, academia and other stake holders in pharma industry to meet, communicate and establish partnership on pharma R&D. By keynote speech, roundtable discussion, company showcase, exhibition booth and 1-2-1 meeting system, this two-day event will share insightful ideas from Asian pharmaceutical leaders, as well as provide fat chances for you to find potential projects and partners
Biotech Showcase is an investor and partnering conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.
The 2017 event showed a substantial increase in the number of presenting companies, as well as significant growth in the number of attendees and one-to-one meetings. Now in its tenth year, Biotech Showcase 2017 is expected to feature presentations by close to 400 public and private companies and attract more than 3,000 attendees. The event will run a full program of topical plenary sessions and workshops, including special-focus events dedicated to emerging trends
The 2017 event showed a substantial increase in the number of presenting companies, as well as significant growth in the number of attendees and one-to-one meetings. Now in its tenth year, Biotech Showcase 2017 is expected to feature presentations by close to 400 public and private companies and attract more than 3,000 attendees. The event will run a full program of topical plenary sessions and workshops, including special-focus events dedicated to emerging trends
Join us for the must attend event for companies and investors interested in cross-border investment opportunities. This inaugural program will feature curated presentations, specialized sessions, and networking opportunities. Taking place in conjunction with Biotech Showcase, attendees can leverage a vast network of China, US, and EU based companies and investors.
- Access to workshops with industry leaders from China, US and EU
- Keynotes highlighting industry trends, new investment and BD opportunities
- Networking opportunities to engage with global life science partners
- International audience of public and private companies and investors
Riding on the success of the meeting last year, Biologics Innovation and Frontier Technology (BIFT 2017) is the definitive conference in China for receiving first-hand information on the current international status of the Biopharmaceutical industry and China’s biopharmaceutical opportunities, bringing together decision makers across C level management, R&D and Manufacturing in the realms of biologic drugs, biosimilars, biotech and Immuno-oncology sectors
After last year' P4 China 2016 has attracted more than 600 professionals in Beijng, this year, the topics will be more focused and in-depth. Concatenated by biomarker, genomics, medical big data, liquid biopsy, oncology drug development and CDx, will become the main theme of 2nd P4 China 2017. P4 China 2017 will be held from Nov 30 to Dec 3 in Guangzhou, to bring together the government, academia, industry, venture capitals, integrate policy, investment, technology, application, and business elements, brainstorm ideas, and to boost the development of precision medicine industry!
Allen & Overy / Lingmed invitation to 'The Globalisation of China Life Sciences' Seminar
Novermber 16, 2017, Shanghai, China
Allen & Overy and Lingmed cordially invite you to an insights-sharing and strategic discussion on what has happened and what is likely to happen to the China life sciences market. Please join us on 16 Novermber at Allen & Overy's Shanghai office to exchage your views and prepare yourself for this rapidly changing market
2017 China BioMed Innovation and Investment Conference (CBIIC) is co-hosted by Securities Association of China (SAC), China Pharmaceutical Innovation and Research Development Association (PhIRDA) and China Association for Medical Devices Industry (CAMDI) which brings together the largest leading experts of innovated and translational research institutions, innovative drug development pharmaceutical and biotech companies and investment institutions as the organizing committee members.CBIIC will showcase biotechnology companies, academic institutions, state biotechnology centers, investment funds in China, as well as innovated drug development companies in the US ,Australia, Asia, Europe and Canada
“The China Biomanufacturing Single Use Conference 2017” is going to be held on the 26th-27th Oct. 2017 in Shanghai. This conference will gather 200+ worldwide leading biopharmaceutical companies, biotechnology companies, CDMOs/CMOs; Single use solution providers, Materials suppliers, Associations and Regulators etc. to address standards and guidance protocols that address the use of disposable products and single use systems in biomanufacturing; Single use system verification requirements and localized verification services; the process and patient safety issues associated with leachables and extractables; Discuss the interoperability of Single Use System; How to Control the Risk in the Supply Chain etc.
Know about the latest Chinese and international laws and regulations to ensure products compliance. 2. Get the latest information about the development of generics to achieve the consistency. 3. Share bioequivalence test plan design to improve the pass rate of bioequivalence test. 4. Discuss about the innovation of chemical drugs development, drug delivery system and formulation. 5. Understand novel new drugs project approval and optimization of lead compounds. 6. Take part in the discussion of bundling review of formulation, pharmaceutical packaging materials and excipients. 7.Provide a platform for representatives from pharmaceutical companines, institutes and universities to communicate with each other
BioPharm America™ is where biotech industry partnerships get started. This conference provides a proven and highly productive format for establishing new business relationships. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, the world's leading web-based partnering system for the life science industry, BioPharm America is the only event in North America based on the same reputable formula as EBD Group's acclaimed European events BIO-Europe® and BIO-Europe Spring®
2017 China Healthcare Summit of Entrepreneurs, Scientists and Investors
September 22–24, 2017, Beijing, China
The 9th China Healthcare Summit of Entrepreneurs, Scientists and Investors will be held in Beijing from 22nd to 24th of September in 2017. We sincerely welcome you to join this event as our distinguished guest. The summit is coordinated by Chinese Pharmaceutical Enterprises Association, supported by Chinese Peasants and Workers Democratic Party’s Central Healthcare and Biotechnology Working Committee and executed by Healthcare Executive magazine. The summit was named as Chinese Pharmaceutical Entrepreneurs Annual before. The Chinese Pharmaceutical Entrepreneurs Annual has become the high-end dialogue platform with the largest influence, the strongest representativeness and the most entrepreneurs after eight consecutive years
Bio Partnering APAC 2017 is the most powerful way to make big deals in bio pharma industry in Asia Pacific Region. Against the background of increasing government policy support, exciting biotechnology breakthroughs and growing venture capital investment, themed on “Open Innovation, Strategic Cooperation”, Bio Partnering APAC 2017 will continuously provide you with the latest knowledge, tools and expertise to set your own global business strategy
From Clinical Trials to Market Access, and against the bedrock of Regulatory Compliance, PharmaCon Asia will bring to you the full spectrum of the drug development and commercialisation value chain. The 4th Annual Congress is back with a new look, a compelling speaker line up and the opportunity to network across 3 separate events in one go. Conference Highlights: 60+ Commercial and Technical Papers; 12+ hours Of networking; 150+ Global, Regional and Local companies; Clinical Trial Trends, Spend areas, Regional Market updates and Operational Excellence; Market Access - Case Studies, Strategies and Practical Tips from Pharma; Regulatory Affairs Interpretation and implementation around the region, and practical compliance options
Organised by the Singapore affiliate of the International Society for Pharmaceutical Engineering (ISPE), this annual meeting is open to all pharma and bio manufacturing Professionals, with this year’s theme as “Innovating for Next Generation Pharma Manufacturing”. It is the must-attend industry event which highlights best practices, technology and services from manufacturing facility design to finished product. Conference Highlights: MORE! 20+ manufacturer and regulator insights, 6 Conference Tracks, 3 Workshops and 3 Tours, 5 Panel Discussions / Q&A round tables, ISPE PharmaNite & Networking Dinner, Regional Student Poster Competition Final, NEW! Breakfast Networking Session Exclusively for ISPE members, NEW! Blood Donation Drive with Red Cross
Asian Biosimilars 2017 is a global annual event which brings together scientists, researchers, business development managers, CEOs, directors, IP Attorneys, Regulatory Officials and CROs from around the world. This conference would be your single best opportunity to reach the largest assemblage of participants from the Biosimilars community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research works, and receive name recognition at this 3-day event. World-renowned speakers, the most recent research, advances, and the newest updates in Biologics and Biosimilars are hallmarks of this conference. This conference would be your single best opportunity to reach the largest assemblage of participants from the biologics and biosimilars community
Over the years, China has increasingly become the hotbed and destination for the clinical research. From one side, increasingly global pharmaceutical companies have recognized the importance and advantages to integrate China into the global early and late phase clinical development but also meanwhile the china clinical research markets are further driven and facilitated by the rapidly transforming China Local R&D Innovation
Now is its 16th year, BioTaiwan 2017 is 5 events in 1, including the BioBusiness Asia Conference, Greater China & Asia-Pacific Opportunities Conference, BioTaiwan Exhibition, Company Presentations, One-on-one Partnering and a full Seminar and Workshop program. It's only a click away to discover the opportunities that await in biotech investment, collaboration, innovation and services
World Preclinical Congress focuses on the very latest trends and technologies impacting preclinical drug discovery and development. World Preclinical Congress 2017 offers a unique opportunity for chemists, biologists, pharmacologists and translational scientists in industry and academia to come together with technology providers to network and collaborate. Coverage includes conferences and short courses on topics including: Medicinal Chemistry, Oncology, Screening, 3D Models, CRISPR, CNS, Drug Toxicity and Blood-Brain Barrier
Bio-Forum is hosted by Modern Biotechnology & Pharmaceutical Industry Office of Shanghai Municipality and supported by Ministry of Science & Technology of the P.R.C, State Food and Drug Administration, Science & Technology Commission of Shanghai Municipality, Shanghai Food and Drug Administration, etc., has evolved into an influential international conference in the area of biotechnology and pharmaceutical industry. This year, the host has decided to sponsor “BIO-FORUM 2017” which will be held at W Shanghai - The Bund on June 7-9,2017. Nearly 100 well-known experts, scholars, entrepreneurs and government officials from home and abroad will be invited to give excellent speech and about 600 delegates will attend the forum. The forum consists of the following parts: Keynote Speech, Parallel Sessions, Partnering, and Exhibition
ChinaBio® Partnering Forum has grown to be the premier life science partnering conference in China. Now in our 9th year, 2016 attracted over 900 decision makers from around the world, including nearly 300 from the US and Europe and 600 from China. For the first time, on May 31 - June 1, 2017, the event will be held in Zhuhai, an emerging hub of life science in Southern China. Zhuhai is committing significant funding and resources to the life science industry, including building the state-of-the-art Jinwan Biopharmaceutical Park, with 250,000 m2 of incubator, R&D and manufacturing facilities. The ChinaBio conference features EBD Group’s partneringONE® system, enabling delegates to efficiently arrange 1-1 meetings with companies from across the life science value chain
LINGMED LIMITED SHANGHAI together with Venture Valuation is pleased to invite you to a full-day workshop on pharma – biotech Product and Company Valuation
• Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world
• Know how to assess and calculate the value of a biotech company
• Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal
• Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world
• Know how to assess and calculate the value of a biotech company
• Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal
On May 21-24, 2017, the DIA China Annual Meeting will bring together global pharmaceutical professionals to discuss critical topics and themes surrounding the regulation, discovery, development, and life cycle management of health care products. The theme of this meeting, “Drug Innovation Driven by Unmet Medical Needs,” will attract more than 2000 pharmaceutical R&D professionals from different continents and regions, involved at all levels of the health care product development spectrum. Please join us to discuss recent and upcoming transformational changes for China’s innovation and regulatory environments
Biopharma Development and Production Week China
May 15-18, 2017, Hilton Shanghai Hongqiao Hotel, China
The Biopharma Development & Production Week is the leading industry platform for pharma, biotech, CMOs, CROs, research institutes, investors, technology and industry stakeholders to meet, network and discuss current industry trends, establish business partnerships and be updated on investment opportunities in China and surrounding Asia.
This year’s Biopharma Development and Production Week China will feature 3 co-located events: 8th Annual Biosimilars Asia, 7th Annual Biomanufacturing and 6th Annual Cell Line Development & Engineering
The Best Media is pleased to announce the launch of the Generic International Summit Asia 2017 in in Shanghai, China.taking place between the 20th & 21th April 2017. Best Media will gather all the essence and global resources into this conference to bring further information and experience sharing. Speakers at this summit are from the two aspects of the pharmaceutical industry: Regulatory Updates and Technology & Market. Meanwhile, the committee will provide four panel discussion on the specific practice of generics consistency evaluation and Case study and experience sharing for generic submission in overseas market
Beijing Bio-Welcome Pharmaceutical Co., Ltd. has been dedicated to provide professional business services for domestic and international pharmaceutical enterprises, particularly in the FDA and the SFDA IND, NDA, ANDA , DMF reporting and Clinical Trials, Pre-IND Meeting, Pre-NDA Meeting, Bioequivalence, etc.. Helping domestic and foreign investment institutions and pharmaceutical companies in China to look for projects in the fields of health and medicine business
The 7th Asia Pharma R&D Leaders 2017 is designed to be a premium strategic platform for big pharmas, biotechs, academia and other stake holders in pharma industry to meet, communicate and establish partnership on pharma R&D. Leading executives from the industry will discuss key topics from global R&D trends, development strategies, Innovation capability building to collaboration opportunities. Besides the extensive knowledge and practical experience, you will also gain incredible value through the customized 1-2-1 meetings during the event. This summit will leave you with a wealth of knowledge contacts and help you to optimize R&D strategy in Asia for the next 12 months
BIT's 9th Annual World Congress of Vaccine (WCV-2017) will be held in Beijing, China during March 29-31, 2017. The WCV has enjoyed an exciting history covering all aspects of vaccines since 2008. The conference is designed to encourage the exchange of ideas across a broad range of disciplines. It has been the international meeting place for healthcare professionals, scientists and researchers, and veterinarians, vaccine manufacturers, and public health officials. Themed 'New Technologies, New Vaccines' this year's conference future to address following topics: Vaccine R & D and New Technologies, Human Vaccines for Major Diseases, Veterinary Vaccines, and Vaccines Production and Manufacturing.The three-day Conference will cover valuable presentations by a wide range of expert speakers and opinion leaders from around the world to encourage the exchange of ideas across a broad range of disciplines
The ICA-2017, with the theme of “New Darling of Immunotherapy” will be held during March 29-31, 2017 in Beijing, China. The program this year will highlight some recent breakthrough stories and successes in this particular field. We are especially interested in presentations in the following major aspects: Global Antibody Market Outlook, Policy and Business; Forefront in Antibody Research and Advanced Technologies; Next Generation Antibodies for Cancer Immunotherapy; New Antibody for Non-cancer Therapy; and Antibody Engineering and Production. The meeting will bring together over 200 experts and specialists from all over the world
International Congress of Biotherapy-2017 will be held during March 29-31, 2017 in Beijing, China. this year’s conference future to address following topics: tumor immunotherapy, stem cell therapy, gene therapy, protein and peptide drug discovery, antibody, vaccines, biosimilar, RNAi therapy. it will attract more than 1000 participants from 30 countries, 150 reports and 80 exhibition boothes
The 8th Annual China Healthcare Investment Conference (CHIC) theme for 2017 is “Growth vs. Innovation: What Drives China’s Healthcare Market?” CHIC will focus on healthcare investment opportunities and trends in China and also “cross-border” with the U.S. and other Western markets. As always, CHIC features perspectives from leading venture capital, private equity, and public equity investors as well as prominent Chinese and international healthcare companies
The 2nd Annual Pharmaceutical Congress China, part of IBC’s PharmaCon Series, will co-locate 3 events: Pharmaceutical Compliance, Patient-Centric Clinical Trials, and Clinical Trials Site Selection & Quality.
From addressing pharmaceutical compliance challenges and issues, driving clinical operation efficiencies and discovering new clinical design technologies, to clinical trials site selection and quality assurance, Pharmacon China 2017 promises to cover in-depth issues pertaining to compliance and clinical trials in China’s pharmaceutical industry
From addressing pharmaceutical compliance challenges and issues, driving clinical operation efficiencies and discovering new clinical design technologies, to clinical trials site selection and quality assurance, Pharmacon China 2017 promises to cover in-depth issues pertaining to compliance and clinical trials in China’s pharmaceutical industry
The BioCon Conference consists of 4th World-China Biosimilars Forum ( Host: BMAP Global; Co-organizer: Shanghai Henlius Biotech) and 3rd Biopharmaceutical Innovation and Development Symposium (Host: BMAP Global; Organizer: Shanghai Jiao Tong University Engineering Research Center of Cell & Therapeutic Antibody, MOE ). BioCon2017 will invite about 50 leaders in the biopharmaceutical field to share their cutting-edge researches and have a full discussion about the hottest issues in this field with about 400 attendees
LINGMED is pleased to invite you to China group Barcelona dinner & Biotech valley visit
March 22, 2017 18:00 - 21:00 China group dinner
March 23, 2017 10:00 - 17:00 Visit biotech companies
March 22, 2017 18:00 - 21:00 China group dinner
March 23, 2017 10:00 - 17:00 Visit biotech companies
Access a world of opportunities through life science partnering at Bio-europe spring. The premier springtime partnering conference bringing together a "whoʼs who" from biotech, pharma and finance in Europe's most innovative biopharma clusters. Bio-europe spring offers various opportunities to engage with global life science partners
eyeforpharma Medical Affairs is a platform for global medical leaders to position their organisation as a business critical partner. The role of Medical Affairs is changing, and the insights generated will help shape decisions across the entire organisation.Medical, reinvented: become the strategic partner shaping the future of pharma New skills for a new era: equip your team for advancements in analytics, communication and technology Volume to value: generate the insights that drive decisions and the shift to an outcomes-based business model United we stand: align with commercial colleagues, external partners and patients at this hyper-networked event
The BIO Asia International Conference co-hosted by BioCentury and Japan Bioindustry Association (JBA) brings together the global biotechnology and pharmaceutical industry to explore licensing and research collaborations in the current Asia-Pacific business and policy environments. Gain insights into the changes, challenges, and opportunities key opinion and policy leaders foresee for the Japanese biotech market. The format and selective nature of the conference makes this the premier dedicated biotech partnering event in Asia and an unrivaled opportunity to meet with the leading international pharmaceutical and biotech companies in one place at one time
Biotech Showcase™ is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco during this critical week which is widely viewed as setting the tone for the coming year.
Now in its ninth year, this rapidly growing conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings.
In addition to biopharmaceutical and life science company executives, Biotech Showcase delegates include investors in private and public companies, sector analysts, bankers and industry professionals
LINGMED LIMITED SHANGHAI together with Venture Valuation is pleased to invite you to a full-day workshop on pharma – biotech Product and Company Valuation
• Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world
• Know how to assess and calculate the value of a biotech company
• Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal
• Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world
• Know how to assess and calculate the value of a biotech company
• Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal
We are holding the P4 China 2016 in the first year of national 13th Five-Y ear Plan Precision Medicine plan's implementation and the new era of 4P Medicine (Predictive, Preventive, Personalized and Participatory), to bring together professionals from governance, industry, academia, research institutes and capitals, help integrate different ideas from policy, supervision, capital, technology, clinical practices and business, and to facilitate the development of Precision Medicine Industry. This convention will gather over 800 famous experts, senior directors from leading players in this field from home and abroad.
Many new drug regulations and policies have been issued this year, including New Marketing Authorization Holder (MAH) system, updated Chinese Pharmacopoeia, clinical trials self-examination, package material compatibility, generics consistency evaluation policies, which cause a lot of pressure to pharmaceutical companies. A great change may take place in pharmaceuticals industry. How to understand these new regulations and policies better, how to communicate with regulators, and how to implement these regulations and policies is one of the biggest challenges that pharmaceutical companies face currently.
Hence, World-China Pharmaceuticals R&D Forum 2016, which is a brand annual summit in this industry, will gather drug regulatory agency officials, industry leaders and representatives from leading pharmaceutical companies from home and abroad to share their opinions and suggestions about the hot topics, such as changes of pharmaceuticals registration regulations, generics consistency evaluation, new targets discovery, compound development and screening strategy, innovative formulations and routes of administration improvement as well as pre-clinical and clinical model design. Besides they will also offer high practical solutions and ideas to help enterprises to develop pharmaceuticals in a compliant, efficient and low-cost way.
Hence, World-China Pharmaceuticals R&D Forum 2016, which is a brand annual summit in this industry, will gather drug regulatory agency officials, industry leaders and representatives from leading pharmaceutical companies from home and abroad to share their opinions and suggestions about the hot topics, such as changes of pharmaceuticals registration regulations, generics consistency evaluation, new targets discovery, compound development and screening strategy, innovative formulations and routes of administration improvement as well as pre-clinical and clinical model design. Besides they will also offer high practical solutions and ideas to help enterprises to develop pharmaceuticals in a compliant, efficient and low-cost way.
BIO-Europe? 2016 - 22nd Annual International Partnering Conference
November 7–9, 2016, Cologne, Germany
The 22nd annual BIO-Europe? event is the largest biotechnology partnering conference held in Europe. Over 3,500 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry's most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
ChinaTrials is the leading high-end event for senior-level clinical development executives to network and discuss the challenges currently facing China and North Asia global development.
We focus on quality of audience, not quantity by specifically aiming for a group of around 350-400 attendees. We believe that this is the right number to ensure that our audience is mad.
We focus on quality of audience, not quantity by specifically aiming for a group of around 350-400 attendees. We believe that this is the right number to ensure that our audience is mad.
China Pharmaceutical Entrepreneurs Annual(CPEA) will be held on Oct 28-30 at Beijing, China.
China (Taizhou) International Medicine Expo will be held in the China Medical City Conference & Exhibition Trade Center in Taizhou, Jiangsu from Oct.28 to Oct 30, 2016. The expo will try to set up a platform for international communication and cooperation, create opportunities for discussions and investments for medical innovations and industrial development, by taking the subject of "strengthening the integration between technology and finance and boosting the achievement transformation of renovation, as well as holding a series of activities like Exhibition &Display, summit forum, matchmaking for innovation products and seminars, etc. We sincerely welcome the pharmaceutical productive, research and development enterprises at home and abroad as well as relevant organizations to participate in the seventh China (Taizhou) International Medical Expo!
the 6th Annual Drug Delivery and Formulation Asia Summit (DDF Asia 2016)
October 27-28, 2016, Shanghai, China
The Best Media is pleased to announce the launch of the 6th Annual Drug Delivery and Formulation Asia Summit at the Holiday Inn Shanghai Nanxiang, taking place between the 27th & 28th October 2016.
This summit provides drug delivery and specialty pharmas with a platform to present their technologies and get the latest insights on what the delivery and formulation needs are. And presents a strategic level program for pharma and biotech business development professionals with a thorough overview of the latest drug delivery technologies available along with an update on deals and opportunities to improve therapies and extend the life cycle of a drug.
What makes this summit unique - over the two days, the attendees will be given the opportunity to network with top level international industry professionals in pre-arranged one-to-one meetings, benchmark against their competition and discuss future business opportunities whilst building long term strategic relationships.
The 3rd BioCentury China Healthcare Summit will gather top thinkers from industry, academia and finance to identify who will lead China's biopharma innovation ecosystem, how innovation will be funded, and the business strategies required to transform both domestic and multinational biopharmas and medtech companies as China advances its innovation agenda. Attendance is limited at this strategic, VIP-only event to ensure intimate dialogue and networking among peers.
Bio Partnering APAC 2016 is a powerful way for you to make big deals in bio pharma industry in Asia Region. The meeting will provide you with latest knowledge, tools and expertise to set global business strategy. With 2 days of insightful panel discussions you will learn global partnering trends and how to make deals in global pharma industry. The new session for company presentation will make it possible for you to learn potential projects with less time and the self-arranged schedule during the event will let you have more flexible time for one-on-one meetings and make deals with higher possibilities.
BioPharm America™ 2016—9th Annual International Partnering Conference
September 13–15, 2016, Boston, MA, USA
BioPharm America™ is where biotech industry partnerships get started. This three-day conference provides a proven and highly productive format for establishing new business relationships. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, the world's leading web-based partnering system for the life science industry, BioPharm America is the only event in North America based on the same reputable formula as EBD Group's acclaimed European events BIO-Europe® and BIO-Europe Spring®. In 2015, BioPharm America attracted 850+ delegates from over 525 companies who participated in 2,350+ scheduled one-to-one meetings.
Join us at BioTaiwan 2016 - one of the largest biotech events in Asia.
Discover, Connect, Succeed.
Now is its 15th year, BioTaiwan 2016 is 5 events in 1, including the BioBusiness Asia Conferences, Greater China Opportunities Conference, BioTaiwan Exhibition, Company Presentation, One-on-one Patnering and a full Seminar and Wrokshop program. It's only a click away to discover the opportunities that await in biotech investment, collaboration, innovation and services.
Discover, Connect, Succeed.
Now is its 15th year, BioTaiwan 2016 is 5 events in 1, including the BioBusiness Asia Conferences, Greater China Opportunities Conference, BioTaiwan Exhibition, Company Presentation, One-on-one Patnering and a full Seminar and Wrokshop program. It's only a click away to discover the opportunities that await in biotech investment, collaboration, innovation and services.
CPhI China is the most comprehensive pure pharma focused event for domestic and international pharmaceutical companies in Asia. Bringing together over 35,000 pharma professionals from more than 120 countries around the world, attendees get the opportunity to meet, network, do business, share ideas and shape the future of the Chinese pharmaceutical industry.
The Second Pharmaceutical Forum Summit, hosted by the editorial committee of PPS(Progress in Pharmaceutical Sciences), China Pharmaceutical University and Chinese Pharmaceutical Association, will be held from June 18 to June 20 in Suzhou, Jiangsu Province. The topic this year mainly focuses on Chinese new drug research and development in the perspective of Globalization. It aims to build an innovative platform for new drug R&D, and discuss how to achieve the internationalization of Chinese new drug industry.
ChinaBio® Partnering Forum is a premium life science partnering forum in China. To be held in May 18th to 19th 2016 in Suzhou, CBPF will attract leading companies from life science and pharmaceuticals industry all over the would and hundreds of Chinese new technology developers to join in this global cooperation event which have achieved remarkable results in the past.
Last year, CBPF have more than 850 attendees from 25 countries and 400 companies, making it China's largest-scale international partnering-focused conference. Our online cooperation system partnering ONE® is going to assist again this upcoming CBPF event, helping attendees screen companies from the whole life science value chain and then set up meetings and eventually establish good business relationship.
Last year, CBPF have more than 850 attendees from 25 countries and 400 companies, making it China's largest-scale international partnering-focused conference. Our online cooperation system partnering ONE® is going to assist again this upcoming CBPF event, helping attendees screen companies from the whole life science value chain and then set up meetings and eventually establish good business relationship.
The Leading Series in China with More Quality Content & a Strong Following of Top BioPharma Stakeholders!
The Biopharma Development & Production Week is the leading industry platform for pharma, biotech, CMOs, CROs, research institutes, investors, technology and industry stakeholders to meet, network and discuss current industry trends, establish business partnerships and be updated on investment opportunities in China and surrounding Asia.
Biopharma Development & Production 2016 incorporating:
- 5th Annual Cell Line Development & Engineering Asia
- 6th Annual Biomanufacturing
- 7th Annual Biosimilars Asia
Biopharma Development & Production 2016 incorporating:
- 5th Annual Cell Line Development & Engineering Asia
- 6th Annual Biomanufacturing
- 7th Annual Biosimilars Asia
The Best Media is pleased to announce the launch of the Generic International Summit Asia 2016 in in Shanghai, China, taking place between the 21th & 22th April 2016. Best Media will gather all the essence and global resources into this conference to bring further information and experience sharing. Speakers at this summit are from the two aspects of the pharmaceutical industry: Regulatory Updates and Technology & Market. Meanwhile, the committee will provide four panel discussion on the specific practice of generics consistency evaluation and Case study and experience sharing for generic submission in overseas market.
VacChina 2016,on its 6th year running, is the largest international vaccine event gathering in China and covers the entire value chain of the global human and veterinary vaccine industry. Here, we will invite local and international experts, industry leaders, scholars to discuss the latest industrial trends, R&D progress, partnership models,manufacturing technology advancements, market strategy and commercialization in China and emerging markets;Meanwhile, we will also build an international communication and collaboration platform for international and local organizations from industry and academia so as to expedite local and global vaccine industry development.
In its third year, "PEGS China: Protein and Antibody Engineering & Development Summit" returns to Shanghai to bring you 3 days of inspiring presentations and case studies featuring the latest trends in protein and antibody engineering, innovation concepts in next-generation biologics, cutting-edge tools in analytical characterization and creative strategies to overcome protein aggregation. Plus, new this year is a Seminar on clinical and regulatory strategies for domestic and global IND and BLA filings. Learn more http://www.PEGSummitChina.com
BIO-Europe Spring® 2016 — 10th International Partnering Conference
April 4-6, 2016, Stockholm, Sweden
BIO-Europe Spring is the springtime counterpart to EBD Group's flagship conference, BIO-Europe, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group's sophisticated, web-based partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative startups.
CHIC's theme for 2016 is "Bridging, Innovation and Fast Adoption" - with perspectives from private equity investors, public equity investors, leading Chinese companies, global companies with operations in China, and goverment/industry experts.
The 7th CHIC will focus its discussions on investment opportunities in both organic and cross-border innovations in China and the best ways to bring them to commercial success. The discussions will cover a broad spectrum of industry sub-sectors such as pharmaceuticals, medical technologies, healthcare services, and eHealth.
The 7th CHIC will focus its discussions on investment opportunities in both organic and cross-border innovations in China and the best ways to bring them to commercial success. The discussions will cover a broad spectrum of industry sub-sectors such as pharmaceuticals, medical technologies, healthcare services, and eHealth.
3 Significant Events Under 1 Roof! The Pharmaceutical Congress China, part of IBC’s PharmaCon Series, recognizes the importance of regulation, clinical operation efficiencies, tackling pharmaceutical compliance issues and bringing products and services successfully in the market in China’s rapidly advancing pharmaceutical industry. Packed with case studies from market leaders, three agendas will unite to create a hub of research, innovation, improved regulatory frameworks, best practice business and operational models that will define China’s pharmaceutical future.
The 9th annual Biopharma Asia Convention 2016 brings together C-level attendees from pharmas, biotechs and service providers to learn and discuss market trends and biologic development strategies. Established as a true one-stop shop for all things biopharma, our 2016 program will be bigger than ever before, offering you 6 premium conference tracks that will explore innovation in clinical trials, manufacturing, supply chain, market access, partnering, pricing, vaccines & infectious diseases, antibodies, orphan drugs, biosimilars and more.
The World-China Novel Vaccines Forum (short for WCVF) will take place in Shanghai on 16-17, March, 2016. The Forum is organized by BMAP Global and has received support from CMC, Henlius, SAPA and ISV. The Forum will invite about 30 speakers and up to 150 participants, mostly experts from vaccine industry, are estimated to participate.
The Forum will bring together hot spots and challenges of novel vaccines, focusing especially on the challenges of quality control over novel vaccines during industrialization, how to exert high quality management in enterprises, how to shorten R&D time and costs and quicken the steps of marketing new vaccine products.
The Forum will bring together hot spots and challenges of novel vaccines, focusing especially on the challenges of quality control over novel vaccines during industrialization, how to exert high quality management in enterprises, how to shorten R&D time and costs and quicken the steps of marketing new vaccine products.
The 3rd World-China Biosimilars Forum (short for WCBF) will take place on March 16-17, 2016 in Shanghai China.The Forum is organized by BMAP Global and has received support from CMC, one of the leading Governmental Bio-tech Industrial Park in China, Henlius, SAPA and ISV. The Forum will invite about 30 speakers and up to 280 participants, mostly from leading players in the Biopharmaceutical sector from China and Worldwide, are estimated to participate.
The World-China Biosimilars Forum is the only international annual conference in China that presents as a platform for technical exchange and strategic cooperation among Chinese biosimilar and vaccine players, Chinese regulators and global leading biopharmas. During the past activities, up to 800 participants worldwide from the biology-pharmacy industry has participated and shared their thoughts, and some 60 of them are well-known industry leaders.
The World-China Biosimilars Forum is the only international annual conference in China that presents as a platform for technical exchange and strategic cooperation among Chinese biosimilar and vaccine players, Chinese regulators and global leading biopharmas. During the past activities, up to 800 participants worldwide from the biology-pharmacy industry has participated and shared their thoughts, and some 60 of them are well-known industry leaders.
The 13th Annual BIO Asia International Conference is an exclusive, customized partnering forum that brings together U.S. and European drug development companies with Asian biotech and pharmaceutical companies interested in research collaborations and licensing agreements. The conference features private, pre-arranged one-on-one meetings between senior-level executives, using BIO’s proprietary, state-of-the-art computer software. The format and selective nature of the conference makes this the premier dedicated biotech partnering event in Asia and an unrivaled opportunity to meet with the leading international pharmaceutical and biotech companies in one place at one time.
Biotech Showcase™ is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences. Now in its eighth year, Biotech Showcase 2016 is expected to attract upwards of 2,100 attendees. The program includes lunch plenary sessions featuring top industry leaders and innovators speaking on industry- and time-relevant topics, as well as presentations from both private and public companies.
In its first year, Biolatam® exceeded expectations with over 700 registrations and 29 countries represented. Partnering was also quickly embraced with 839 one-to-one meetings scheduled over the two-day span. This year we bring Biolatam in its second edition to Santiago, Chile, a city with a vibrant life science community. Hosted this year by Chile Biotech, ProChile and Asembio, the conference has strong European and US support and is expected to draw an even bigger audience of engaged life science professionals.
The 5th Clinical Project Management Workshop - Essentials of Project Management
November 11-13, 2015, Beijing, China
This skills and case study based hands-on course is designed to provide a high degree of working knowledge in the intermediate to advanced level clinical project management techniques necessary for managers, senior managers, and directors of both clinical research and clinical project management. The course will help participants to better understand the scope of management, be able to conduct the time management, cost management, risk management and conflict management. The course covers clinical project management from the planning stage through development, execution, and project close-down.
Now in its 8th year, CHINATRIALS is the leading industry-focused clinical development event designed specifically for director-level and above executives with interest in China development. What differentiates CHINATRIALS is our focus on attracting the highest-quality audience of 350-400 attendees who are the senior-level decision makers from all the BioPharma/Device companies (global and local) with activities in China.
The 21st annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 3,200 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
The 6th China (Taizhou) International Medical Expo 2015
October 30 - November 1, 2015, Taizhou, Jiangsu
The 6th China (Taizhou) International Medical Expo will be held on Oct.30-Nov.1 in Taizhou, Jiangsu Province, China. Last year, this Medical Expo attracted more than 3000 attendees from more than 10 countries and regions, including the United States, Britain, Germany, Singapore, Israel, India, Hong Kong, Taiwan, etc.. The exhibition area this year reaches 17000㎡, of which the special booth is nearly 50, and standard booth is about 220.
BioChina International 2015 Summit is a leading partnering and networking platform for bio industry in China and other parts of the world. Here, you will learn how to do bio business in China and find numerous partnering opportunities no matter you are a start-up biotech, a MNC, an investor, or a new comer. The event aims to promote the communication and collaboration between China and global bio industry so as to accelerate fast and healthy development of China biopharma industry.
DIA, a neutral and global organization with 50 years of history of excellence in providing scientific and educational meetings and programs in the pharmaceutical and other healthcare fields, will offer its 1st conference and exhibition in Drug Discovery Innovation this coming October, which covers topics from drug design target to Phase IIA, proof of concept. We, unlike many commercial meeting organizers, have attracted a group of world-class leaders in the fields who have both international visions and real China experience to guide us in creating the meeting programs and contents.
China(Nanjing) International Health Industry Exhibition
Sep 21-23, 2015, Nanjing International Expo Center
Following the success of the last edition, 2015 Biotech China--The All China Biotech Conference & Exhibition will be held on Sep.21-23 in Nanjing International Expo Center. Biotech China, Sponsored by China Quality Association for Pharmaceuticals and China Health Industry Alliance, represents the top level of China bio industry. 2015 Biotech China will welcome more world wide famous exhibitors, pay more attention to build trade platform, hold more frontier conferences and forums. The curtains of distinguished Bio Party will be opened.
BioPharm America™ 2015 - 8th Annual International Partnering Conference
Sep 15-17, 2015, Marriott Copley Place, Boston
BioPharm America™ is where biotech industry partnerships get started. This three-day conference provides a proven and highly productive format for establishing new business relationships. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships.
As the premier event focusing on the development of the medical device industry, DeviceChina advocates an active healthy industrial ecosystem, provides an event to exchange ideas on cutting-edge industrial trends and enables a professional communication platform for fostering successful device development strategies. Since the inaugural event in 2011, the summit has been held successfully for the past four years. Well-known medical device inventors, scientists, entrepreneurs, investors and executives from both China and overseas at- tend each year, earning the conference a strong reputation within the industry. The 2014 summit was a great success, over 300 of the most influential industry leaders from both China and overseas gathering at Suzhou Dushulake. The summit received wide praise from speakers and attendees.
Given the rapid growth of the biologics industry in China and increasing interest in innovative biologics beyond biosimilars, IBC is proud to launch Antibody Engineering & Therapeutics China in 2015. This event will bring together leading scientists and innovators from around the world to discuss novel strategies for antibody, protein and biotherapeutic discovery and development.
BioProcess International Conference & Exhibition China
August 12-13 2015, Grand Hyatt Hotel, Shanghai China
Providing comprehensive coverage of China's evolving biologics market for the last 6 years, this conference will help you find process development and manufacturing strategies to help you accelerate biologics to market. Learn about new approaches for upstream and downstream development, biomanufacturing/facilities and analytical/quality for a wide-range of biotherapeutics.
Bringing 4 Significant Events Under 1 Roof!
August 3-6 2015, Grand Copthone Waterfront hotel, Singapore
The Pharmaceutical Congress Asia recognizes the importance of navigating through the complexities of Asia’s unique healthcare environments, regulation, clinical research capabilities and operational efficiencies to successfully bring pharmaceutical products and services to the market. Packed with case studies from market leaders, three agendas will unite to create a hub of research, innovation, improved regulatory frameworks, best practice business, marketing and distribution models that will define Asia’s pharmaceutical future.
BioPh Summit China 2015 brings together top experts and scientists from biopharma, legislation, venture capital, etc. as well as leading technology solution providers from all over Asia and the rest of the world.
International Pharma Logistics Exhibition 2015
June 24-26, 2015 Shanghai New International Expo Center
International Pharma Logistics Exhibition (P-Logi) gathers exhibitors and providers of logistics equipment, technologies and services on pharmaceutical industries. It is the leading industry platform in Asia for supply chain and logistics decision makers, logistics service suppliers and all other industry stakeholders to meet, network and discuss latest industry trends, partnership models and new technologies in Asia.
The 17th Shanghai International Forum on Biotechnology & Pharmaceutical Industry (BIO-FORUM 2015)
June 8-10, 2015 Shanghai International Convention Center
BIO-FORUM 2014 will have a major focus on “Creating Opportunities through Change”. Nearly 100 well-known experts, scholars, entrepreneurs and government officials from home and abroad will be invited to give excellent speech and about 600 delegates will attend the forum.
World Orphan Drug Congress Asia 2015
June 3-4, 2015 Suntec Singapore Convention & Exhibition Centre, Singapore
Gain insights into expediting orphan drug development & guaranteeing speedy reimbursement in Asia's market at this year’s World Orphan Drug Congress Asia 2015. This 3-4 June in Singapore, join a series of thought-provoking discussions ranging from discovery to clinical development, manufacturing, licensure & product launch. Hear from Dato' Eisah A.Rahman, Senior Principal Director, Pharmaceutical Services, Ministry of Health , Malaysia and Kevin Huang, President, Chinese Organization for Rare Disorders (CORD) , China among others.
ISPE Singapore’s Conference continues to focus on the needs of the regional pharmaceutical manufacturing industry to improve product quality and to raise overall productivity. International and regional speakers drawn from the regulatory, manufacturing and services spheres will share their views and insights on current issues and challenges.
Medtech Partnering Forum Japan will provide insights into new developments in the rapidly changing medical technology industry in Japan and share best practices on how to enter into new marketplaces. Featuring EBD Group's sophisticated, web-based partnering system, partneringONE, the event enables delegates to efficiently identify, meet and do business with attending companies, from large international medtech companies to emerging companies to investors.
Themed on "Innovation and Convergence - Building a Sustainable R&D Ecosystem", it is the largest multidisciplinary event DIA has in Asia, bringing together a global network of professionals to foster innovation that will lead to the development of safe and effective medical products and therapies for patients. The 7th DIA China Annual Meeting provides a great platform and excellent networking opportunities to share knowledge, experiences, successes, and solutions, and to build new relationships.
This event will highlight exciting developments in cell line engineering, explore efficient best practices in bioprocessing techniques, as well as delve into cutting edge techniques in antibody development, all under-one-roof. Gain best practice tools and processes which will increase efficiency, productivity and ensure quality in production for companies of all sizes.
This event will examine the latest regulations impacting, analyse new and existing facilities, introduce cost saving technologies, and discuss best practices to meet the growth of biologic products in Asia. Key biological manufacturers will share their learnings, challenges and strategies to both advance and refine this developing industry. This conference also aims to provide a platform for key industry experts to have in-depth discussions on biomanufacturing facilities, process and quality
At IBC’s Biosimilars Asia Conference, top industry players will explore practical strategies for gaining access to emerging markets, clarifying regulatory pathways and clinical approvals, evaluating business models, risks and investment opportunities, pricing and commercialization strategies and successful case studies.
2015 International Pharmaceutical Innovation and Technology Transfer Conference
May 15, 2015(13:00-18:00) Shanghai, China
The conference employing "innovation, cooperation, integration and development" as its
theme, converges domestic and foreign pharmaceutical innovation resources, presents
international forefront of pharmaceutical innovation. By various channels, such as promotion
of key projects, project information release, project exhibition and negotiation &
cooperation, the conference is to act as an international platform for the transfer and
cooperation of domestic and foreign pharmaceutical projects.
ChinaBio® Partnering Forum is the premier life science partnering event in China. Held on April 15-16, 2015, in Shanghai, the event will attract biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for two days of productive partnering.
ChinaBio® Partnering Forum 2014 had more than 848 delegates from 425 companies and 25 countries, making it the largest partnering conference in China. The 2015 edition promises to be even better with top notch attendance from pharma and biotech companies as well as leading researchers from China's top universities and institutes.
The conference also features partneringONE®, enabling delegates to efficiently identify, meet and network with companies from across the life science value chain.
ChinaBio® Partnering Forum 2014 had more than 848 delegates from 425 companies and 25 countries, making it the largest partnering conference in China. The 2015 edition promises to be even better with top notch attendance from pharma and biotech companies as well as leading researchers from China's top universities and institutes.
The conference also features partneringONE®, enabling delegates to efficiently identify, meet and network with companies from across the life science value chain.
China Healthcare Investment Conference (CHIC)
March 31 – April 2, 2015 Pudong Shangri-La Hotel - Shanghai, China
The China Healthcare Investment Conference is the premier event of its kind in China. As the leading event of the year focusing on rapidly growing Chinese healthcare companies, the Conference will be a great opportunity to meet with emerging companies, industry leaders, key governmental officials and avid investors from China and the West. The conference brings together those company executives, entrepreneurs, investors, services providers and government officials interested in and committed to the development of the China healthcare industry.
13th Annual eyeforpharma Barcelona 2015 is the leading commercial pharma event in the world to address customer empowerment. As your customer takes charge this meeting will enable you take the steps necessary to become their partner of choice. 1000+ delegates, 80+ C-Suite and Director level speakers, 3 focussed tracks http://goo.gl/LUH1xm
The BIO Asia International Conference, co-hosted by the Biotechnology Industry Organization (BIO), BioCentury and the Japan Bioindustry Association (JBA), brings together the global biotechnology and pharmaceutical industry to explore licensing and research collaborations in the current Asia-Pacific business and policy environments. Gain insights into the changes, challenges, and opportunities key opinion and policy leaders foresee for the Japanese biotech market.
Asia’s biopharmaceutical industry is entering a period of opportunity; the need for industrial collaborations to foster innovation and change has never been more important. The 8th BioPharma Asia Convention is the most prestigious regional gathering of pharma and biotech executives, investors, academics and solution providers. It is the perfect platform for companies to launch new products, gain valuable insights from key industry stakeholders and maintain relationships with their clients.
BIO-Europe Spring? is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe?, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group’s sophisticated, web-based partnering system, partneringONE?, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative startups.
BioLink BioPharm Innovation and International Technology Transfer Summit 2015
January 22-23, 2015 Beijing Yizhuang Biomedical Park
This event will gather 200+ decision makers of biopharmaceutical industrial players within China and globally, from biologics, life science technologies, biopharmaceuticals, bio equipment, to CRO and analytical instruments. It is an unparalleled platform for regulatory updates and analysis, technical presentations, technology transfer project promotions, business connections, and partnership development, through a series of networking opportunities including speed name card exchanging, project match making and private meetings.
国药励展与中国化学制药工业协会在第72届全国药品交易会同期共同举办。届时将邀请政府相关部门领导、国内科研院所、院校的专家学者,瞄准国际技术前沿与企业关注的热点及难点问题,到会作具有指导性和前瞻性的专题报告。同时,将组织制药相关新产品、新技术、新工艺、新设备等的推介和展示。希望通过对药物制剂及辅料问题的探讨,企业能在解决药品质量瓶颈的关键技术问题上有所收获与体会,探索建立有效的产学研联盟机制,以期在将来的工作实践中与科研机构找到合作切入点,形成合作互利的双赢局面。
为提高科技成果转化效率,集合资源优势,强化项目、资本、载体三者的有效融合,在第72届全国药品交易会期间,主办方为您精心组织策划了以“创新、合作、整合、发展”为主题的“第二届国际医药创新与技术转移大会”,汇聚国内外医药创新资源,分享国际医药创新前沿,同时,将采用重点项目推介、项目信息发布、项目展示、合作洽谈等多种方式为医药项目的国内外转移与合作提供展示、沟通舞台,为业界精心打造我国“医药技术流动交易所”。
PharmaVenue offers unparalleled opportunities to establish new business relationships with mid-sized companies from 35 countries through pre-scheduled one-to-one meetings with decision makers.Our state-of-the art interactive partnering software enables you to efficiently select the most attractive license opportunities, pre-arrange and conduct many productive business meetings with matching interests to unlock future revenue streams.
BIT's 4th Annual Symposium of Drug Delivery Systems-2014 (SDDS2014)
November 18-20, 2014 Suzhou, China
Starting from a clinical need, the development of enhanced therapeutics through the application of appropriate drug delivery technology bears great opportunities but remains a challenge at the same time. The SDDS-2014 program will follow the path of drug delivery system development and showcase some of the cutting edge technologies, latest developments and efficient methodologies. This is achieved by more than 150 oral presentations of key opinion leaders and more than 500 posters on the latest advanced technologies trends in drug delivery systems. SDDS offers a unique possibility to discuss with additional 300 colleagues and friends worldwide who are expected to join us in Suzhou. The SDDS is also the place where collaboration starts.
As one of the life science and pharmaceutical industry's most international and most often held partnering events for business deals, euroPLX will be held for the 56th time. At euroPLX 56 Nice you will meet pharma and biopharma executives who are in charge of their companies' business development.
由中国医药工业信息中心、中国医药企业发展促进会、国药励展和39健康网联合主办的“2014医药战略峰会”将于2014年11月26日,在广州天河新天希尔顿酒店举行。在互联网冲击下,医药产业正呈现出前所未有的多维度资源整合,跨界之声此起彼伏。面对产业生态的巨变,行业普遍身处一种茫然与焦虑的情绪之中。本届大会以“直面产业链融合与重构-对话‘医・工・商’”为主题,围绕远程治疗、电子商务、大数据等为新特征的互联网经济对医疗医药行业所产生的挑战及机遇,特邀请行业专家、企业高管、医院院长从各自所侧重的角度和领域进行深入剖析和经验分享。同时,大会还将针对近期产业政策热点对行业产生的影响进行分析和研究,主要涉及二三级医院与基层医院采购模式的变化、社区医院药房社会化的可行性、提升药品流通服务水平和效率工作的设想等内容。
Through case studies, lectures, posters and exhibitions, the aim of MolMed-2014 is to offer further high quality programs with the new Molecular Medicine technologies, to not only scientists but also ordinary delegates. The program of the coming MolMed-2014 conference would be of great interest to both basic scientists and executives who are working in the field of medicinal chemistry and other related areas. The newly updated developments and findings will be presented in the exciting meeting.
ChinaTrials is the leading high-end event for senior-level clinical development exceutives to network and discuss the challenges currently facing China and North Asia global development. We focus on quality of audience, not quantity by specifically aiming for a group of 350-400 attendees. We believe that this is the right number to ensure that our audience is made up of decision-makers from the pharmaceutical, biotech and medical device sectors.
BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. Produced with the support of BIO, it is regarded as a “must attend” event for the biotech industry.
China Forum 2014 will be a full-day event, bringing together China-based life science executives with their counterparts from Europe and the rest of the world. The event will provide insights into recent developments of the rapidly changing life science industry in China. Executives from China and the West will discuss partnering opportunities and attendees will gain essential knowledge on how to step into new marketplaces. In an interactive setting, attendees from Western countries will hear what it takes to succeed in China, and Chinese executives will learn how to leverage their business by partnering with European and American companies.
IBC Asia’s OTC Pharma China Conference brings together international and local senior executives investing in Over – the- Counter (OTC) and Traditional Chinese Medicine (TCM) in China and North Asian market segments. It will discuss current market trends and future outlooks, opportunities for market access and growth, global expansion strategies, as well as brand building and equity strategies to stand out in a crowded and highly competitive field.
Medica Group is proud to announce the 5th Emerging Market Access conference on October 8 2014, in Paris :
· One place, one date to gather USA/MENA/BRIC/EMEA‘s main representatives to share their market access strategies, best practice and strategic positions.
· Attendees are mainly key people of market access and pricing & health economic departments from big and mid pharmaceuticals as well as experts in market access from consulting firms.
· A unique format: morning plenary sessions and afternoon workshops dedicated to the MENA, Brazilian, Russian, Chinese and Indian pharma market, and numerous coffee breaks and seated lunch to develop your business network.
· Workshops of 90 minutes, presented by 3 speakers and a moderator.
· Interactive presentations of 15/20 minutes, with a lot of attention for Q&A
· One place, one date to gather USA/MENA/BRIC/EMEA‘s main representatives to share their market access strategies, best practice and strategic positions.
· Attendees are mainly key people of market access and pricing & health economic departments from big and mid pharmaceuticals as well as experts in market access from consulting firms.
· A unique format: morning plenary sessions and afternoon workshops dedicated to the MENA, Brazilian, Russian, Chinese and Indian pharma market, and numerous coffee breaks and seated lunch to develop your business network.
· Workshops of 90 minutes, presented by 3 speakers and a moderator.
· Interactive presentations of 15/20 minutes, with a lot of attention for Q&A
BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings (2.775) and companies participating (762).
BioPharm America™ is where biotech industry partnerships get started. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, the world’s leading web-based partnering system for the life science industry, BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®.
The mission for Partnerships in Clinical Trials Asia is to provide clinical leaders a forum to execute high-quality research through strategic partnerships and strong operational capabilities. No other event in the region provides the quality of personal interaction needed to understand the infrastructure, capabilities, opportunities, and risks for conducting clinical research in Asia.
DeviceChina aims at advocating a healthy industrial ecosystem for the high-end Chinese medical devices market. The event serves as an efficient platform for medical device inventors, scientists, entrepreneurs, investors and executives to communicate and collaborate. Elite experts from various backgrounds will exchange ideas on cutting-edge industrial trends and share the best strategies to help drive the development of the industry forward.
2014第十五届北京国际医疗器械展览会内容全面涵盖了包括医用电子、医学影像设备、光学、急救、康复护理、医疗用品及卫生材料、检验设备及诊断试剂以及医疗信息技术等产品,直接并全面服务于医疗器械行业从源头到终端整条医疗产业链。
IBC Asia’s Pharma R&D Asia conference brings to you insights into Asia’s pharmaceutical industry, its challenges, partnerships and investment opportunities and potential that the region holds. This conference aims to illustrate with expert insight and case studies, the key investment trends and market developments transforming Asia’s pharmaceutical R&D landscape.
IBC's 6th Annual BioProcess International China conference is the region's foremost event on bioprocessing and biomanufacturing. It provides you with the most timely information, tools, strategies and techniques that you need to ensure optimal development, from upstream to scale-up to commercialization.
As one of the life science and pharmaceutical industry's most international and most often held partnering events for business deals, euroPLX will be held for the 55th time. At euroPLX 55 Vienna you will meet pharma and biopharma executives who are in charge of their companies' business development.
「Biopharm 国际生物医药展」是由HNZ鸿与智商业媒体旗下的PI《医药界》杂志、国际医药资源网组织发起,邀请国内外知名行业协会/学会、科研院所,由HNZMEDIA鸿与智商业媒体和合肥联贸媒会展服务有限公司共同主办,致力于促进生物医药合作与贸易发展,搭建专业的信息交流与贸易平台。生物医药展以发展成亚洲最专业的生物医药展展为目标,迄今为止已经成功举办了5届,已吸引了来自全球10余个国家和地区逾500家企业的参与。本届展会将于2014年6月18日-20日在上海世博馆举办,集中展示生物制药与技术、分析仪器、实验室设备等,是行业内不可错过的专业展会。
The14th China (Shanghai) International Medical Devices Exhibition 2014
June 11-13, 2014 Shanghai, China
CMEH2014第十四届中国(上海)医疗器械展览会将于6月11日—13日将在上海世博展览馆隆重举行,作为最具规模及影响力的医疗器械领域盛会 ,CMEH将整合资源为国内外医疗器械厂商提供一个既能做出口也能做国内贸易的平台展会,让国内外展商更能有效开拓国际和国内市场。
The 16th Shanghai International Forum on Biotechnology and Pharmaceutical Industry
May 22-24, 2014 Shanghai, China
BIO-FORUM 2014 will have a major focus on "Innovative Technology & Healthcare". Nearly 100 well-known experts, scholars, entrepreneurs and government officials from home and abroad will be invited to give excellent speech and about 600 delegates will attend the forum.
The 4th Shanghai International Medical Device and Biotechnology Exhibition
May 22-24, 2014 Shanghai, China
To further motivate development of medical device and biotechnology industry in Shanghai, Modern Biotechnology & Pharmaceutical Industry Office of Shanghai Municipality will hold "The 4th Shanghai Medical Device and Biotechnology Exhibition" at Shanghai International Convention Center on May 22nd-24th ,2014.
IBC’s 5th Annual Biosimilars Asia will bring together senior level biosimilars development,
manufacturing and commercialization decision makers from Asia and globally.
It provides an unrivalled platform to find solutions to the most pressing strategic challenges
as well as innovations in development of biosimilars.
Held once a year in China, the DIA China Annual Meeting is expected to attract 1400 participants. As the largest annual meeting held in the Asia Pacific region, the DIA China Annual Meeting will provide a neutral platform for information exchange, featuring speakers that include high-level representatives from government, industry and academia in China and abroad.
ChinaBio® Partnering Forum is the premier life science partnering event in China. Held on May 7–8, 2014, in Suzhou, the event will attract biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for two days of productive partnering.
EuroMedtech™ is Europe's leading medical technology partnering conference, providing collaboration opportunities to medtech decision makers and investors. EuroMedtech caters to companies involved in all parts of the advanced medical technology industry, from those serving mainline therapeutic categories such as orthopedics and cardiovascular, through diagnostics, imaging and eHealth to those involved in platform technologies such as biomaterials and regenerative medicine. Also attending are companies serving the industry, such as manufacturers, law firms, CROs and distributors.
With a wide range of companies from all areas of
pharma active in Japan as well as free to attend seminars presented by
governmental bodies and other important institutions, CPhI Japan is
all you need to successfully enter this highly profitable market.
The BIO Asia International Conference is an exclusive customized partnering forum that brings together U.S.
and European drug development companies with Asian biotech pharmaceutical companies interested in research
collaborations and licensing agreements. The conference features private, pre-arranged meetings between
senior-level executives, using BIO’s proprietary state-of-the-art computer software, BIO One-on-One Partnering ™.
The format and selective nature of the conference makes this the premier dedicated biotech partnering event in Asia.
The summit allows companies to gain insight into the international medical market and offers the opportunity of international collaboration. It will gather 300 participants including CEOs of global medical device companies, VCs/PEs and Investment Banks, academic authorities, medical experts and government officials. They will focus on exploring medical innovations and transformation, financing strategies, industry development and investment strategies as well as M&A, IPO and fund raising.
China Med 2014
The 26th International Medical Instruments & Equipment Exhibition
The 26th International Medical Instruments & Equipment Exhibition
March 21-23, 2014 Beijing, China
CHINA MED is one of the most influential
exhibitions in Chinese medical instruments and equipment industry.It is
aiming to become the prevailing exhibition in China's medical instrument
and equipment industry, a showcase of world-leading products and
technologies, and a platform for the advanced academic theories and
practice under the tenet of high-end event and academic authorization.
BIO-Europe Spring® is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe®, and continues the tradition of providing life science companies with high caliber partnering opportunities.
The China Healthcare Investment Conference (CHIC), now in its 5th year, has established itself as the most important event of its kind by bringing together the leading Chinese healthcare companies, both public and private, with the leading investors in the sector. Come meet the CEOs, CFOs, CSOs, VC/PE investors, fund managers and advisors who are creating the healthcare companies most likely to succeed in China over the next 3-5 years.
The 4th Annual China Healthcare Investment Conference (CHIC) was held March 12-14,2013 in Shanghai and was attended by 400 of the industry's most influential Chinese and global thought leaders.
The 4th Annual China Healthcare Investment Conference (CHIC) was held March 12-14,2013 in Shanghai and was attended by 400 of the industry's most influential Chinese and global thought leaders.
如何及时掌握先进的生物技术,如何利用先进技术开发新的体外诊断产品,国内诊断企业如何找到新的突破口,跨国项目合作能否进入更深度阶段,试剂科研如何迈向产学研一体化,这些炙手可热的问题将在2014年中国先进体外诊断技术高峰论坛上展开深入探讨!
BIOASIA the annual international event; is being hosted
at Hyderabad in HICC Hyderabad. You will meet leaders, scientists, CEO's of
biotechnology, pharmaceutical companies and venture capital companies,
teachers, researchers and students are the target visitors.
在印度海得拉巴举行。你将见到业内领导人,科学家,生物科技公司,制药公司以及投资公司的CEO, 教师,科研人员,同时学生等等。
在印度海得拉巴举行。你将见到业内领导人,科学家,生物科技公司,制药公司以及投资公司的CEO, 教师,科研人员,同时学生等等。
Drug Delivery Partnerships is hailed by all as the world's
most authoritative conference on collaboration to drive progress in drug
delivery. Your roadmap to success starts here at DDP14; the only event
that delivers the perfect mix of technology, insights and innovation.
New for 2014: advance your drug delivery strategy with new technology
and new Partners with partneringONE, the state-of-the-art one-to-one partnering
tool. Discover innovative products, take advantage of trends and jumpstart
strategic relationships to leap ahead of the curve.